Incentivizing innovation requires the protection of intellectual property rights. Allowing compounded pharmacies to sell ...

Henry Meds is a subscription-based telehealth platform that focuses on treatment for endocrine-related conditions. Offerings ...

The company is one of two major players in the rapidly growing obesity drug market. Yet, the stock has lost half its value.

Doctors called it “huge for patients,” if true. Patients who’ve struggled to afford the pricey medicines shared hope the ...

A state law shields its source of pentobarbital, the sedative used in lethal injections. But documents reviewed by NBC News ...

Shares of Hims & Hers Health are trading lower Friday morning after comments from President Donald Trump indicated that he ...

An alliance of scientists at the Broad Institute and Bayer Pharmaceuticals have developed a drug candidate, sevabertinib, ...

Shares of Eli Lilly and Novo Nordisk move lower in Thursday's after-hours session after President Trump indicated weight-loss ...

People are trying mini doses of GLP-1 drugs to lose weight or maintain weight loss, but doctors urge caution, calling the ...

Zions takes $50 million loan loss as another credit ‘cockroach’ appears. Regional-bank stocks are falling. Archaeologists ...

Leading makers of GLP-1 (Glucagon-Like Peptide-1) weight loss drugs like Ozempic and Zepbound are facing off against domestic compounding pharmacies that import foreign ingredients and make cheaper, ...

Plants are consummate chemists, using the sun's energy and carbon dioxide from the air, to conjure a dazzling array of ...